Comment on the article: “Incidence of pulmonary thromboembolism in patients with COVID-19 pneumonia”
Main Article Content
Keywords
Incidence, Prevalence, COVID 19, Thromboembolism, Chi-square Distribution
Abstract
This letter to the editor presents key concepts on research designs, prevalence and incidence, as well as statistics for comparing dichotomous variables, highlighting the difference with likelihood ratio. A Chi2 exercise with the study data is included to illustrate the methodology. Finally, a brief description of the pathophysiological mechanism linking COVID-19 infection with pulmonary thromboembolism is provided.
References
1. Talavera JO, Roy-García I, Palacios-Cruz L, et al. De vuelta a la clínica. Métodos I. Diseños de investigación. Mayor calidad de información, mayor certeza a la respuesta. Gac Med Mex. 2019;155:399-405. Disponible en: https://doi.org/10.24875/GMM.19005226.
2. Rivas-Ruiz R, Castelán-Martínez OD, Pérez-Rodríguez M, et al. Investigación clínica XVII. Prueba χ2, de lo esperado a lo observado. Rev Med Inst Mex Seguro Soc. 2016;51(5):552-7. Disponible en: https://revistamedica.imss.gob.mx/index.php/revista_medica/article/view/918
3. Ugoni A, Walker BF. The Chi square test: an introduction. COMSIG Rev. 1995;4(3):61-4.
4. Aznar-Oroval E, Mancheño-Alvaro A, García-Lozano T, et al. Razón de verosimilitud y nomograma de Fagan: 2 instrumentos básicos para un uso racional de las pruebas del laboratorio clínico. Rev Calid Asist 2013;28:390-1. Disponible en: https://doi.org/10.1016/j.cali.2013.04.002.
5. Grillet F, Behr J, Calame P, et al. Acute pulmonary embolism associated with COVID-19 pneumonia detected with pulmonary CT angiography. Radiology. 2020;296:E186-8. Disponible en: https://doi.org/10.1148/radiol.2020201544.
6. Ortega-Paz L, Talasaz AH, Sadeghipour P, et al. COVID-19-associated pulmonary embolism: Review of the pathophysiology, epidemiology, prevention, diagnosis, and treatment. Semin Thromb Hemost. 2023;49:816-32. Disponible en: https://doi.org/10.1055/s-0042-146 1757634.
